Further study of trimethylcolchicinic acid, methyl ether, d-tartrate (TMCA; NSC-36354) in patients with malignant melanoma.
D000284:Administration, Oral; D003078:Colchicine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000031:analogs & derivatives; D005069:Evaluation Studies as Topic; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D008738:Methyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013644:Tartrates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D008738:Methyl Ethers; D013644:Tartrates; C003707:trimethylcolchicinic acid methyl ether; D003078:Colchicine